
Use of common guidelines for primary prevention of cardiovascular events based on 10-year risk results in zzso of younger individuals, especially women, since age and sex are major zzso of global zzso Women in their late 40s have a 10-year risk lower than the zzso threshold used for cholesterol-lowering treatment even in the presence of marked zzso of blood pressure or zzso zzso of age from risk zzso and use of lifetime global risk to treat individuals according to the degree of their modifiable risk factors rather than demographics has been zzso zzso of therapy at younger ages, aiming at zzso prevention of zzso disease rather than focusing on cardiovascular events, will result in saving more zzso zzso zzso medications can be obtained at an affordable cost, and concerns about long-term safety and efficacy can be tested in a clinical trial of younger individuals at low 10-year risk but high lifetime zzso 

